Benign prostatic hyperplasia (BPH) is one of the most common diseases facing aging men and impacts quality of life by causing lower urinary tract symptoms (LUTS).  However, most men suffer symptoms for years before consulting with a healthcare provider for reasons such as being embarrassed or believing that changes in urinary function are just “part of getting older.” As such, it is important to ask patients about LUTS and prostate-related concerns and identify patients who need treatment.

A minimally invasive treatment option for patients with moderate-severe LUTS secondary to BPH called UroLift® System Treatment is available.  http://urolift.com

The new treatment has been approved worldwide and published 5 year durability data. Clinical data have shown the following:

  • Rapid symptom relief as early as 2 weeks post-procedure with only mild urinary discomfort post-procedure during the recovery period
  • The procedure can be performed under local anesthesia
  • Successful urethral expansion may be immediately confirmed endoscopically post-procedure
  • Some patients may not need post treatment catheterization
  • There have been no reports of new onset of sexual dysfunction, retrograde ejaculation or permanent erectile dysfunction
  • The most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure

To better assess your needs, please call us!